Table A3.
Mean differences in resistance rates for P. aeruginosa in ICUs versus other wards per antibiotic during the 2 years (2017–2018).
| P. aeruginosa | Int. Med. A | Pulm. A | Int. Med B | Pulm. B | Cystic | Urol. |
|---|---|---|---|---|---|---|
| Amikacin | 26.71% * | 19.61% * | 18.30% * | 29.76% * | −0.40% | 13.70% |
| Aztreonam | 12.25% | 7.13% | 11.61% | 7.43% | 9.65% | 7.73% |
| Cefepime | 25.04% * | 19.00% * | 22.11% * | 26.31% * | 10.36% | 24.73% * |
| Ceftazidime | 26.49% * | 20.68% * | 22.21% * | 24.17% * | 18.74% * | 35.80% * |
| Ciprofloxacin | 24.42% * | 16.99% * | 10.07% | 21.72% * | 20.45% * | 7.02% |
| Colistin | 2.59% | 1.27% | −0.27% | 1.98% | −3.44% | 2.59% |
| Doripenem | 16.52% | 25.90% * | 16.07% | 29.14% * | 21.05% * | 32.04% * |
| Gentamicin | 24.64% * | 23.33% * | 17.97% * | 26.23% * | 0.43% | 16.09% |
| Imipenem | 28.78% * | 23.35% * | 18.14% * | 27.65% * | 15.63% * | 26.54% * |
| Levofloxacin | - | 26.77% * | −0.21% | 25.86% * | 19.13% * | - |
| Meropenem | 27.25% * | 25.35% * | 20.52% * | 29.57% * | 23.01% * | 26.92% * |
| Piperacillin/tazobactam | 26.04% * | 19.57% * | 23.70% * | 23.17% * | 18.60% * | 26.29% * |
| Tobramycin | 24.94% * | 18.52% * | 12.96% | 27.07% * | 15.10% * | 15.07% |
* p-value is less than 0.05.